Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousCombined Modality TherapyMelphalanMultiple MyelomaHematologic NeoplasmsGranulocyte Colony-Stimulating FactorLeukapheresisAntineoplastic Combined Chemotherapy ProtocolsAntigens, CD34Treatment OutcomeBlood Component RemovalCyclophosphamideMyeloablative AgonistsRemission InductionGraft vs Host DiseaseRecurrenceBusulfanLymphoma, Non-HodgkinStem CellsBone Marrow TransplantationHematopoietic Stem CellsGraft SurvivalAmyloidosisEtoposideThiotepaAntineoplastic Agents, AlkylatingSalvage TherapyCarmustineHodgkin DiseaseVincristineIfosfamideDisease-Free SurvivalCytarabineCytophagocytosisRetrospective StudiesSurvival RateHematopoiesisTissue DonorsCord Blood Stem Cell TransplantationWhole-Body IrradiationSurvival AnalysisTransplantation ChimeraNeoplasmsTime FactorsDoxorubicinBone Marrow PurgingHistocompatibilityDexamethasoneImmunosuppressive AgentsHistocompatibility TestingInfectionThalidomidePrednisoneFollow-Up StudiesPlatelet CountLeukemia, Myeloid, AcuteCarboplatinCytomegalovirus InfectionsLymphoma, T-CellBoronic AcidsPyrazinesLymphomaAntineoplastic AgentsPOEMS SyndromeFatal OutcomeLeukemiaProspective StudiesVidarabineTransplantation, IsogeneicRecombinant ProteinsFeasibility StudiesBlood Cell CountGraft vs Leukemia EffectPrognosisMyelodysplastic SyndromesOpportunistic InfectionsBlood Transfusion, AutologousBlood CellsMesenchymal Stem Cell TransplantationEmbryonic Stem CellsAnemia, AplasticImmunophenotypingAdult Stem CellsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematologic DiseasesT-LymphocytesPrecursor Cell Lymphoblastic Leukemia-LymphomaLymphocyte DepletionBone MarrowKidney TransplantationCyclosporineHLA AntigensFlow CytometryImmunosuppression